Skip to main content
Top
Published in:

Open Access 01-12-2023 | Aortic Dissection | Study protocol

Scandinavian trial of uncomplicated aortic dissection therapy: study protocol for a randomized controlled trial

Authors: Claudina Rudolph, Beate Rikken Lindberg, Timothy Resch, Kevin Mani, Patrick Björkman, Elín Hanna Laxdal, Henrik Støvring, Henriette Margrethe Beck, Gunnar Eriksson, Jacob Budtz-Lilly

Published in: Trials | Issue 1/2023

Login to get access

Abstract

Background

Contemporary management of uncomplicated type B aortic dissections (uTBAD) is based on the acuity and various morphological features. Medical therapy is mandatory, while the risks of early thoracic endovascular aortic repair (TEVAR) are balanced against the potential for rupture, complex surgery, and death. Improved aortic morphology following TEVAR is documented, but evidence for improved overall survival is lacking. The costs and impact on quality of life are also needed.

Methods

The trial is a randomized, open-label, superiority clinical trial with parallel assignment of subjects at 23 clinical sites in Denmark, Norway, Sweden, Finland, and Iceland. Eligibility includes patients aged ≥ 18 with uTBAD of < 4 weeks duration. Recruited subjects will be randomized to either standard medical therapy (SMT) or SMT + TEVAR, where TEVAR must be performed between 2–12 weeks from the onset of symptoms.

Discussion

This trial will evaluate the primary question of whether early TEVAR improves survival at 5 years among uTBAD patients. Moreover, the costs and the impact on quality of life should provide sorely needed data on other factors that play a role in treatment strategy decisions. The common Nordic healthcare model, with inclusion of all aortic centers, provides a favorable setting for carrying out this trial, while the robust healthcare registries ensure data validity.

Trial registration

ClinicalTrials.gov NCT05215587. Registered on January 31, 2022.
Literature
5.
go back to reference Trimarchi S, Tolenaar JL, Tsai TT, Froehlich J, Pegorer M, Upchurch GR, et al. Influence of clinical presentation on the outcome of acute B aortic dissection: evidences from IRAD. J Cardiovasc Surg (Torino). 2012;53:161–8.PubMed Trimarchi S, Tolenaar JL, Tsai TT, Froehlich J, Pegorer M, Upchurch GR, et al. Influence of clinical presentation on the outcome of acute B aortic dissection: evidences from IRAD. J Cardiovasc Surg (Torino). 2012;53:161–8.PubMed
8.
go back to reference Debakey ME, Henly WS, Cooley DA, Morris GC, Crawford ES, Beall AC. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg. 1965;49:130–49.CrossRefPubMed Debakey ME, Henly WS, Cooley DA, Morris GC, Crawford ES, Beall AC. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg. 1965;49:130–49.CrossRefPubMed
11.
go back to reference Erbel R, Aboyans V, Boileau C, Bossone E, Di BR, Eggebrecht H, et al. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adultthe task force for the diagnosis and treatment of aortic diseases of the European So. Eur Heart J. 2014;35:2873–926. https://doi.org/10.1093/eurheartj/ehu281.CrossRefPubMed Erbel R, Aboyans V, Boileau C, Bossone E, Di BR, Eggebrecht H, et al. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adultthe task force for the diagnosis and treatment of aortic diseases of the European So. Eur Heart J. 2014;35:2873–926. https://​doi.​org/​10.​1093/​eurheartj/​ehu281.CrossRefPubMed
29.
go back to reference Huynh TT, Miller CC 3rd, Safi HJ. Delayed onset of neurologic deficit: significance and management. Semin Vasc Surg. 2000;13:340–4.PubMed Huynh TT, Miller CC 3rd, Safi HJ. Delayed onset of neurologic deficit: significance and management. Semin Vasc Surg. 2000;13:340–4.PubMed
Metadata
Title
Scandinavian trial of uncomplicated aortic dissection therapy: study protocol for a randomized controlled trial
Authors
Claudina Rudolph
Beate Rikken Lindberg
Timothy Resch
Kevin Mani
Patrick Björkman
Elín Hanna Laxdal
Henrik Støvring
Henriette Margrethe Beck
Gunnar Eriksson
Jacob Budtz-Lilly
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Trials / Issue 1/2023
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-023-07255-7

Other articles of this Issue 1/2023

Trials 1/2023 Go to the issue